Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
European Journal of Medicinal Chemistry
|
December 12, 2023
Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatment
Wenjian Min, Yanyin Wang, Hongtao Shen, et al.
Journal of Medicinal Chemistry
|
July 14, 2022
Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer
Yi Hou, Fang Zhang, Wenjian Min, et al.
Journal of Medicinal Chemistry
|
October 27, 2023
Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance
Yasheng Zhu, Xiuquan Ye, Hao Shen, et al.
Journal of Medicinal Chemistry
|
February 4, 2026
Discovery of Novel, Potent, and Selective IRAK1 Inhibitors as Potential Therapeutics for Hepatocellular Carcinoma
Wenjian Min, Junfeng He, Qiman Zhang, et al.
Journal of Medicinal Chemistry
|
February 17, 2023
Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer
Kai Yuan, Hongtao Shen, Mingming Zheng, et al.
Journal of Medicinal Chemistry
|
July 9, 2025
Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer
Yasheng Zhu, Hao Shen, Jiayu Ding, et al.
Journal of Medicinal Chemistry
|
October 13, 2021
Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment
Yi Hou, Wenbin Kuang, Wenjian Min, et al.
Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of a Novel and Potent <i>MET</i> Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC
Wenjian Min, Chunling Chen, Zhongrui Shi, et al.
Journal of Medicinal Chemistry
|
December 28, 2024
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents
Chengliang Sun, Yao Cheng, Jingwen Dong, et al.
Journal of Medicinal Chemistry
|
December 9, 2025
Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance
Kai Yuan, Wanqi Wang, Chen Tong, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
European Journal of Medicinal Chemistry
|
December 12, 2023
Discovery of potent and selective c-Met inhibitors for MET-amplified hepatocellular carcinoma treatment
Wenjian Min, Yanyin Wang, Hongtao Shen, et al.
Journal of Medicinal Chemistry
|
July 14, 2022
Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer
Yi Hou, Fang Zhang, Wenjian Min, et al.
Journal of Medicinal Chemistry
|
October 27, 2023
Discovery of Novel Fourth-Generation EGFR Inhibitors to Overcome C797S-Mediated Resistance
Yasheng Zhu, Xiuquan Ye, Hao Shen, et al.
Journal of Medicinal Chemistry
|
February 4, 2026
Discovery of Novel, Potent, and Selective IRAK1 Inhibitors as Potential Therapeutics for Hepatocellular Carcinoma
Wenjian Min, Junfeng He, Qiman Zhang, et al.
Journal of Medicinal Chemistry
|
February 17, 2023
Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer
Kai Yuan, Hongtao Shen, Mingming Zheng, et al.
Journal of Medicinal Chemistry
|
July 9, 2025
Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer
Yasheng Zhu, Hao Shen, Jiayu Ding, et al.
Journal of Medicinal Chemistry
|
October 13, 2021
Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment
Yi Hou, Wenbin Kuang, Wenjian Min, et al.
Journal of Medicinal Chemistry
|
June 3, 2025
Discovery of a Novel and Potent <i>MET</i> Transcription Inhibitor Targeting Promoter G-Quadruplex for the Treatment of NSCLC
Wenjian Min, Chunling Chen, Zhongrui Shi, et al.
Journal of Medicinal Chemistry
|
December 28, 2024
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents
Chengliang Sun, Yao Cheng, Jingwen Dong, et al.
Journal of Medicinal Chemistry
|
December 9, 2025
Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance
Kai Yuan, Wanqi Wang, Chen Tong, et al.
Page
of 5